A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer

Clinical trial NCT03030287 · COMPLETED

Trial details

NCT number: NCT03030287
Sponsor: OncoMed Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer Ovaries Cancer Peritoneal Cancer, Fallopian Tube

Start date: 2016-12-01
Primary completion: 2020-04-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.